Agile therapeutics reports q2 loss per share of $0.12

Agile therapeutics reports second quarter 2020 financial results.q2 loss per share $0.12.q2 earnings per share estimate $-0.14 -- refinitiv ibes data.believe co is on track to launch twirla in q4 of 2020.sees q4 revenue in range of $1 million to $2 million.

AGRX Ratings Summary

AGRX Quant Ranking